▶주메뉴 바로가기
▶본문 바로가기
[ THE INVESTOR ] Medytox, Korea’s largest maker of botulinum toxin, said it has obtained regulatory approval for its new production plant in Osong, North Chungcheong Province. The Korean Ministry ...
[THE INVESTOR] Celltrion founder and chairman Seo Jung-jin will attend an investor roadshow next month ahead of the planned initial public offering of its marketing unit Celltrion Healthcare, the c...
[THE INVESTOR] The Korean government on June 9 decided not to offer insurance coverage for Pfizer’s new breast cancer drug Ibrance, questioning the pricey drug’s cost-effectiveness. The state-run c...
[ THE INVESTOR ] Korean pharmaceutical companies are poised to release a series of important drugs in the second half of this year, industry sources said on June 9. Kolon Life Science’s Invossa, a...
[ THE INVESTOR ] Samsung Bioepis, a biosimilar medicine affiliate of Samsung Group, said on June 8 it will break ground for the construction of a new headquarters near the current building in Song...
[ THE INVESTOR ] Korea’s biopharmaceutical firm Celltrion is pushing ahead with its clinical trial plans for a subcutaneous version of its biosimilar Remsima that will provide more convenient sel...
[ THE INVESTOR ] Celltrion said on June 5 its copy version of Roche’s Herceptin for patients with early breast cancer works as well as the original drug in late-stage trials. The drug, Herzuma, al...
[ THE INVESTOR ] Samsung Bioepis is seeking to develop a biosimilar version of Roche’s Lucentis which treats a visual disorder, Reuters reported on June 2. In a U.S. filing, the company said it pl...
[ THE INVESTOR ] Korean biopharmaceutical firm Green Cross said on June 2 it will invest some 104 billion won (US$92.66 million) in upgrading facilities in the country, to bolster efficiency for ...
[THE INVESTOR] Samsung BioLogics shares hit a record high on expectations of its inclusion in KOSPI200 index and plans for expansion. The stocks climbed 4.09 percent to 229,000 won (US$204.05) at ...
[ THE INVESTOR ] The US prescription sales of Celltrion ’s biosimilar Inflectra rose 10 percent in April compared to the previous month, continuing a five-month upward trend since its launch in t...
[ THE INVESTOR ] Korea’s Ilyang Pharmaceutical said its leukemia drug has been found to be more effective than Novartis’ Gleevec during the final clinical studies. Ilyang’s Supect has been stati...
[ THE INVESTOR ] Genexine has been granted approval to initiate phase 1 and 2 clinical trials of its recombinant thyroid stimulating hormone GX-30 from Korea’s drug regulatory body, the company s...
[ THE INVESTOR ] Korea University Medical Center said on May 26 that it will work with SK C&C to develop an intelligence artificial system that diagnoses antibiotics for patients at hospitals by n...
[ THE INVESTOR ] JW Holdings has signed a contract with India’s Gland Pharma to supply raw materials of antibiotics drug ertapenem worth US$26 million, the company said on May 25. Under the agree...
The Investor launches weekly 'DECODED X'
KEPCO nuke chief to meet NuGen CEO
eBay becomes No. 3 retailer in Korea
Samsung beats Fitbit in wearable sales for first time
Korea probes Audi A7, A8 for emissions rigging
SNU’s self-driving car completes first test drive in city
Facebook mulls data center in Korea
IMM reaps W50b from Celltrion Healthcare ahead of IPO
